Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses

Autor: Julian S. Wehrmann, Christopher Tuffs, Marvin Biller, Cormac T. Taylor, Gwendolyn Kimmer, Alfonso Blanco, Alina S. Ritter, Jonathan M. Harnoss, Thomas Schmidt, Martin Schneider, Moritz J. Strowitzki, Johannes Klose, Vanessa M. Opitz, Praveen Radhakrishnan, Julia Kugler, Ulrich Keppler
Rok vydání: 2021
Předmět:
Zdroj: JCI Insight, Vol 6, Iss 8 (2021)
JCI Insight
ISSN: 2379-3708
Popis: Anastomotic leakage (AL) accounts for a major part of in-house mortality in patients undergoing colorectal surgery. Local ischemia and abdominal sepsis are common risk factors contributing to AL and are characterized by upregulation of the hypoxia-inducible factor (HIF) pathway. The HIF pathway is critically regulated by HIF-prolyl hydroxylases (PHDs). Here, we investigated the significance of PHDs and the effects of pharmacologic PHD inhibition (PHI) during anastomotic healing. Ischemic or septic colonic anastomoses were created in mice by ligation of mesenteric vessels or lipopolysaccharide-induced abdominal sepsis, respectively. Genetic PHD-deficiency (Phd1-/-, Phd2+/-, and Phd3-/-) or PHI were applied to manipulate PHD activity. Pharmacologic PHI and genetic PHD2-haplodeficiency (Phd2+/-) significantly improved healing of ischemic or septic colonic anastomoses, as indicated by increased bursting pressure and reduced AL rates. Only Phd2+/- (but not PHI or Phd1-/-) protected from sepsis-related mortality. Mechanistically, PHI and Phd2+/- induced immuno-modulatory (M2) polarization of macrophages, resulting in increased collagen content and attenuated inflammation-driven immune cell recruitment. We conclude that PHI improves healing of colonic anastomoses in ischemic or septic conditions by Phd2+/--mediated M2 polarization of macrophages, conferring a favourable microenvironment for anastomotic healing. Patients with critically perfused colorectal anastomosis or abdominal sepsis could benefit from pharmacologic PHI.
Databáze: OpenAIRE